M B Taubman
Overview
Explore the profile of M B Taubman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
71
Citations
1598
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Panetta C, Fallon J, Zhang H, Ramirez F, Taubman M
Cardiovasc Pathol
. 2015 May;
7(2):69-74.
PMID: 25990065
Fibrillins are two distinct 350 kD RGD-containing glycoproteins found in microfibrils in the extracellular matrix. Fibrillin-containing microfibrils are required for elastic fiber formation and serve as an anchor for protein...
2.
Lieb M, Taubman M
Methods Mol Med
. 2011 Feb;
30:47-57.
PMID: 21341015
The vast majority of past and present efforts in the molecular cloning of expressed sequences involve isolation of clones from cDNA libraries constructed in bacteriophage lambda (1,2). As discussed in...
3.
Khorana A, Francis C, Menzies K, Wang J, Hyrien O, Hathcock J, et al.
J Thromb Haemost
. 2008 Sep;
6(11):1983-5.
PMID: 18795992
No abstract available.
4.
Spinelli S, OBrien J, Bancos S, Lehmann G, Springer D, Blumberg N, et al.
PPAR Res
. 2008 Feb;
2008:328172.
PMID: 18288284
Historically, platelets were viewed as simple anucleate cells responsible for initiating thrombosis and maintaining hemostasis, but clearly they are also key mediators of inflammation and immune cell activation. An emerging...
5.
Mieszczanska H, Kaba N, Francis C, Gerich J, Dodis R, Schwarz K, et al.
J Thromb Haemost
. 2007 Apr;
5(5):942-9.
PMID: 17461928
Objectives: To evaluate the effects of pioglitazone on insulin sensitivity and levels of biomarkers associated with thrombotic risk in overweight and obese, non-diabetic subjects with coronary artery disease. Background: Little...
6.
Bogdanov V, Kirk R, Miller C, Hathcock J, Vele S, Gazdoiu M, et al.
J Thromb Haemost
. 2006 Jan;
4(1):158-67.
PMID: 16409465
Tissue factor (TF) is a transmembrane glycoprotein that initiates coagulation and plays a critical role in regulating hemostasis and thrombosis. We have recently reported a naturally occurring, soluble form of...
7.
Schecter A, BERMAN A, Yi L, Mosoian A, McManus C, Berman J, et al.
Proc Natl Acad Sci U S A
. 2001 Aug;
98(18):10142-7.
PMID: 11504923
There have been increasing reports of acute coronary thrombotic events in patients with HIV. Although these clinical events have been attributed primarily to dyslipidemia associated with protease inhibitor therapy, autopsy...
8.
Roque M, Reis E, Cordon-Cardo C, Taubman M, Fallon J, Fuster V, et al.
Lab Invest
. 2001 Jun;
81(6):895-903.
PMID: 11406650
Rapamycin, an immunosuppressant and antiproliferative agent, reduces intimal hyperplasia after arterial injury in animal models and in a preliminary study in humans. Rapamycin treatment reportedly increases expression of p27, a...
9.
Poon M, Gertz S, Fallon J, Wiegman P, Berman J, Sarembock I, et al.
Atherosclerosis
. 2001 Mar;
155(2):371-80.
PMID: 11254907
Macrophages play a critical role in the development and progression of atherosclerosis. This study was designed to examine the effect of the glucocorticoid, dexamethasone, (Dex), on macrophage accumulation after acute...
10.
Holness W, Santore T, Brown G, Fallon J, Taubman M, Iyengar R
Proc Natl Acad Sci U S A
. 2001 Feb;
98(3):1288-93.
PMID: 11158632
Interaction between signaling pathways regulates many cellular functions, including proliferation. The Galpha(s)/cAMP pathway is known to inhibit signal flow from receptor tyrosine kinases to mitogen-activated protein kinase (MAPK)-1,2 and, thus,...